Skandinaviska Enskilda Banken (SEB)’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.55M | Hold |
59,061
| – | – | 0.01% | 540 |
|
|
2025
Q1 | $2.04M | Buy |
59,061
+17,547
| +42% | +$607K | 0.01% | 573 |
|
|
2024
Q4 | $1.13M | Buy |
41,514
+11,325
| +38% | +$309K | 0.01% | 645 |
|
|
2024
Q3 | $769K | Hold |
30,189
| – | – | ﹤0.01% | 689 |
|
|
2024
Q2 | $765K | Hold |
30,189
| – | – | ﹤0.01% | 658 |
|
|
2024
Q1 | $933K | Hold |
30,189
| – | – | ﹤0.01% | 663 |
|
|
2023
Q4 | $1.22M | Hold |
30,189
| – | – | 0.01% | 669 |
|
|
2023
Q3 | $796K | Buy |
+30,189
| New | +$796K | 0.01% | 711 |
|
|
2020
Q3 | – | Sell |
-16,700
| Closed | -$545K | – | 1034 |
|
|
2020
Q2 | $545K | Buy |
+16,700
| New | +$545K | ﹤0.01% | 800 |
|